Divestments
Dako
EQT V bought Dako in 2007.
Dako is a world leader in providing systems for cancer diagnostics. Hospital and research laboratories worldwide use Dako reagents, instruments and software to make precise diagnoses and determine the most effective treatment for patients suffering from cancer.
Key Facts
- Sector
Healthcare
- Country
Denmark
- Fund
EQT V
- Entry
2007
- Exit
2012
About Dako
The company has a long history of market leadership and is highly recognized among pathology laboratories around the world. Dako’s headquarters are located in Denmark and the company has approximately 1,100 employees
In 2012 EQT V sold Dako to Agilent Technologies.
Do You Want to Know More?
We are eager to explore how we can achieve great things together.